High Transepidermal Water Loss in Infancy Linked to Eczema

Share this content:
High Transepidermal Water Loss in Infancy Linked to Eczema
High Transepidermal Water Loss in Infancy Linked to Eczema

TUESDAY, Nov. 8, 2016 (HealthDay News) -- High transepidermal water loss (TEWL) in infancy is associated with atopic eczema (AE) at age 2 years, according to a study published online Nov. 3 in the British Journal of Dermatology.

Teresa Løvold Berents, M.D., from the University of Oslo in Norway, and colleagues used data from a cohort of infants living in south-east Norway to examine whether TEWL in infants without AE correlated with AE at age 2 years. Children were examined at two visits at a mean age of 6.0 and 24.0 months. Data on TEWL measurements were obtained at both visits for 116 of 196 children.

The researchers found that 19 of 116 children (16 percent) had AE diagnosed at the second visit. After adjustment for potential confounding variables, high TEWL at the first visit correlated with AE at the second visit (odds ratio, 3.32). The sensitivity and specificity were 0.63 and 0.70, respectively, while positive and negative predictive values were 0.29 and 0.91, respectively. High TEWL at the first visit correlated with AE at the second visit when limiting the cohort to 32 infants aged younger than 3 months at the first visit (odds ratio, 7.67).

"We were able to replicate the findings of a larger study, indicating that skin barrier dysfunction may be present in infants before clinical eczematous lesions in AE appear," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »